ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:December 6, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:December 6, 2023Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:September 28, 2023Recruiting
Condition(s):Hepatosplenic T-Cell LymphomaLast Updated:March 4, 2021Completed
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:March 21, 2017Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:November 18, 2023Recruiting
Condition(s):Cutaneous T Cell Lymphoma; Peripheral T Cell LymphomaLast Updated:August 28, 2023Recruiting
Condition(s):NK/T Cell LymphomaLast Updated:May 24, 2021Unknown status
Condition(s):T-cell Lymphoma; NK-Cell Lymphoma; T-cell Prolymphocytic Leukemia; T-cell Large Granular Lymphocytic Leukemia; Chronic Lymphoproliferative Disorder of NK Cells; Aggressive NK-cell Leukemia; Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder); Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood; Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form; Hydroa Vacciniforme-Like Lymphoproliferative Disorder; Adult T-cell Leukemia/Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Enteropathy-associated T-cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Intestinal T-Cell Lymphoma, Not Otherwise Specified; Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract; Hepatosplenic T-cell Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma; Primary Cutaneous T-cell Lymphoma; Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma; Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Follicular T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; Breast Implant-Associated Anaplastic Large Cell LymphomaLast Updated:December 13, 2023Recruiting
Condition(s):Peripheral T-cell LymphomasLast Updated:August 11, 2015Unknown status
Condition(s):Relapsed/Refractory Peripheral T-Cell Lymphoma; Adult T Cell Leukemia/LymphomaLast Updated:May 26, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.